Recent developments pose reimbursement and compliance challenges for billing and coding infectious disease testing—here’s how to manage them.
Two recent panel discussions focused on why super-clean orders are important in health care and the challenges that currently prevent them.
The new codes have garnered attention as a future mechanism for additional reimbursement and thus deserve further discussion.
Last week’s three key cases included two involving drug testing that was either medically unnecessary, or not provided at all.
To avoid claims denials and improper billings, ensure billing and coding staff is aware of, and has adjusted to, all recent coding changes.